Silvia Di Legge
Overview
Explore the profile of Silvia Di Legge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tarlet J, Taieb J, Di Legge S, Boccara G, Coulon D, Guenoun M
HeartRhythm Case Rep
. 2018 Sep;
4(9):412-414.
PMID: 30228967
No abstract available.
2.
Di Legge S, Hachinski V
Dement Neuropsychol
. 2017 Dec;
4(1):4-13.
PMID: 29213654
Until recently, the study of cognitive impairment as a manifestation of cerebrovascular disease (CVD) has been hampered by the lack of common standards for assessment. The term vascular cognitive impairment...
3.
Sallustio F, Di Legge S
Evid Based Med
. 2015 Sep;
20(6):211-2.
PMID: 26370786
No abstract available.
4.
Diomedi M, Scacciatelli D, Misaggi G, Balestrini S, Balucani C, Sallustio F, et al.
J Neuroimaging
. 2014 Oct;
24(5):473-8.
PMID: 25340183
Background And Purposes: This study aimed to identify clinical and ultrasound imaging predictors of progression of carotid luminal narrowing in subjects with asymptomatic moderate internal carotid artery (ICA) stenosis. Methods:...
5.
Floris R, Cozzolino V, Meschini A, Garaci F, Konda D, Marziali S, et al.
Radiol Med
. 2014 Feb;
119(10):767-74.
PMID: 24567091
Purpose: The efficacy of thrombolytic treatment with recombinant tissue plasminogen activator (rt-PA) within 3 h from stroke onset has been extensively supported by randomised placebo-controlled multicentre trials. In our single-centre...
6.
Sallustio F, Koch G, Di Legge S, Rossi C, Rizzato B, Napolitano S, et al.
J Stroke Cerebrovasc Dis
. 2013 Feb;
22(8):e323-31.
PMID: 23379980
Background: Severely impaired patients with persisting intracranial occlusion despite standard treatment with intravenous (IV) administration of recombinant tissue plasminogen activator (rtPA) or presenting beyond the therapeutic window for IV rtPA...
7.
Diomedi M, Di Legge S, Sallustio F
Stroke
. 2013 Jan;
44(2):e8.
PMID: 23299496
No abstract available.
8.
Di Legge S, Koch G, Diomedi M, Stanzione P, Sallustio F
Stroke Res Treat
. 2012 Dec;
2012:391538.
PMID: 23213626
Prevention plays a crucial role in counteracting morbidity and mortality related to ischemic stroke. It has been estimated that 50% of stroke are preventable through control of modifiable risk factors...
9.
Di Legge S, Sallustio F, De Marchis E, Rossi C, Koch G, Diomedi M, et al.
ISRN Neurol
. 2012 Mar;
2011:959483.
PMID: 22389838
Purpose. We investigated stroke recurrence in patients with acute ischemic stroke of undetermined aetiology, with or without a patent foramen ovale (PFO). Methods. Consecutive stroke patients underwent to Transcranial Doppler...
10.
Sallustio F, Di Legge S, Diomedi M, Stanzione P
Cerebrovasc Dis
. 2011 Sep;
32(3):296-7.
PMID: 21912110
No abstract available.